Consideration of donor age and human leukocyte antigen matching in the setting of multiple potential living kidney donors

Transplantation

Volumn 92, Issue 1, 2011, Pages 70-75

  Rizzari, Michael D ^a,b   Suszynski, Thomas M ^a   Gillingham, Kristen J ^a   Matas, Arthur J ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Mayo Mail Code 609   (United States)

Author keywords

Age; Kidney transplant; Living donor

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; AGE; AGE DISTRIBUTION; AGED; AGING; ARTICLE; COHORT ANALYSIS; DELAYED GRAFT FUNCTION; FEMALE; GRAFT SURVIVAL; HLA MATCHING; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

AGE FACTORS; AGED; COHORT STUDIES; DELAYED GRAFT FUNCTION; DONOR SELECTION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 79959658340     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31821cded7     Document Type: Article

References (51)

1. Boulware LE, Ratner LE, Sosa JA, et al. The general public's concerns about clinical risk in live kidney donation. Am J Transplant 2002; 2: 186.
2. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605.
3. Cecka JM. TheUNOSScientific Renal Transplant Registry-2000. Clin Transpl 2000: 1.
4. D'Alessandro AM, Sollinger HW, Knechtle SJ, et al. Living related and unrelated donors for kidney transplantation. A 28-year experience. Ann Surg 1995; 222: 353.
5. Terasaki PI, Cecka JM, GjertsonDW,et al. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333.
6. Kasiske BL, Snyder JJ, Matas AJ, et al. Preemptive kidney transplantation: The advantage and the advantaged. J Am Soc Nephrol 2002; 13: 1358.
7. Segev DL, Gentry SE, Montgomery RA. Association between waiting times for kidney transplantation and rates of live donation.AmJ Transplant 2007; 7: 2406.
8. Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A paired donor kidney analysis. Transplantation 2002; 74: 1377.
9. Nishikawa K, Terasaki PI. Outcome of preemptive renal transplantation versus waiting time on dialysis. Clin Transpl 2002: 367.
10. Chavalitdhamrong D, Gill J, Takemoto S, et al. Patient and graft outcomes from deceased kidney donors age 70 years and older: An analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database. Transplantation 2008; 85: 1573.
11. Port FK, Bragg-Gresham JL, Metzger RA, et al. Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors. Transplantation 2002; 74: 1281.
12. Ojo AO, Hanson JA, Meier-Kriesche H, et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001; 12: 589.
13. Cecka JM. The UNOS Scientific Renal Transplant Registry. Clin Transpl 1996: 1.
14. Knight RJ, Burrows L. The combined impact of donor age and acute rejection on long-term cadaver renal allograft survival. Surgery 1999; 125: 318.
15. Metzger RA, Delmonico FL, Feng S, et al. Expanded criteria donors for kidney transplantation. Am J Transplant 2003; 3(suppl 4): 114.
16. Kerr SR, Gillingham KJ, Johnson EM, et al. Living donors 55 years: To use or not to use? Transplantation 1999; 67: 999.
17. Sumrani N, Delaney V, Ding ZK, et al. Renal transplantation from elderly living donors. Transplantation 1991; 51: 305.
18. Morrissey PE, Gohh R, Yango A, et al. Renal transplant survival from older donors: A single center experience. Arch Surg 2004; 139: 384.
19. De La Vega LS, Torres A, Bohorquez HE, et al. Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFR. Kidney Int 2004; 66: 1654.
20. Kumar A, Verma BS, Srivastava A, et al. Long-term followup of elderly donors in a live related renal transplant program. J Urol 2000; 163: 1654.
21. Matas AJ, Payne WD, Sutherland DE, et al. 2,500 living donor kidney transplants: A single-center experience. Ann Surg 2001; 234: 149.
22. Fuggle SV, Allen JE, Johnson RJ, et al. Factors affecting graft and patient survival after live donor kidney transplantation in the UK. Transplantation 2010; 89: 694.
23. Oien CM, Reisaeter AV, Leivestad T, et al. Living donor kidney transplantation: The effects of donor age and gender on short- and longterm outcomes. Transplantation 2007; 83: 600.
24. Iordanous Y, Seymour N, Young A, et al. Recipient outcomes for expanded criteria living kidney donors: The disconnect between current evidence and practice. Am J Transplant 2009; 9: 1558.
25. Held PJ, Kahan BD, Hunsicker LG, et al. The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med 1994; 331: 765.
26. Kaneku HK, Terasaki PI. Thirty year trend in kidney transplants: UCLA and UNOS Renal Transplant Registry. Clin Transpl 2006: 1.
27. Opelz G, Wujciak T, Dohler B. Is HLA matching worth the effort? Collaborative Transplant Study. Transplant Proc 1999; 31: 717.
28. Pirsch JD, D'Alessandro AM, Sollinger HW, et al. The effect of donor age, recipient age, and HLA match on immunologic graft survival in cadaver renal transplant recipients. Transplantation 1992; 53: 55.
29. Seikaly M, Ho PL, Emmett L, et al. The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: Renal transplantation from 1987 through 1998. Pediatr Transplant 2001; 5: 215.
30. Matas AJ, Gillingham KJ, Humar A, et al. Immunologic and nonimmunologic factors: Different risks for cadaver and living donor transplantation. Transplantation 2000; 69: 54.
31. Humar A, Kerr S, Gillingham KJ, et al. Features of acute rejection that increase risk for chronic rejection. Transplantation 1999; 68: 1200.
32. Ojo AO, Wolfe RA, Held PJ, et al. Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968.
33. Quiroga I, McShane P, Koo DD, et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006; 21: 1689.
34. Cacho DT, Pique AA, Cusi LI, et al. Living donor renal transplantation: Prognostic factors on graft survival. Transplant Proc 2005; 37: 3679.
35. Lee SY, Chung BH, Piao SG, et al. Clinical significance of slow recovery of graft function in living donor kidney transplantation. Transplantation 2010; 90: 38.
36. Suthanthiran M. Acute rejection of renal allografts: Mechanistic insights and therapeutic options. Kidney Int 1997; 51: 1289.
37. Matas AJ, Gillingham K, Kandaswamy R, et al. Kidney transplant halflife (t1 2) after rapid discontinuation of prednisone. Transplantation 2009; 87: 100.
38. Matas AJ, Kandaswamy R, Humar A, et al. Long-term immunosuppression, without maintenance prednisone, after kidney transplantation. Ann Surg 2004; 240: 510.
39. Humar A, Dunn T, Kandaswamy R, et al. Steroid-free immunosuppression in kidney transplant recipients: The University of Minnesota experience. Clin Transpl 2007: 43.
40. Matas AJ. Minimization of steroids in kidney transplantation. Transpl Int 2009; 22: 38.
41. Textor SC, Taler SJ, Driscoll N, et al. Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation 2004; 78: 276.
42. Ferrari P, de Klerk M. Paired kidney donations to expand the living donor pool. J Nephrol 2009; 22: 699.
43. Segev DL, Kucirka LM, Gentry SE, et al. Utilization and outcomes of kidney paired donation in the United States. Transplantation 2008; 86: 502.
44. Roodnat JI, Kal-van Gestel JA, Zuidema W, et al. Successful expansion of the living donor pool by alternative living donation programs. Am J Transplant 2009; 9: 2150.
45. Delmonico FL, Morrissey PE, Lipkowitz GS, et al. Donor kidney exchanges. Am J Transplant 2004; 4: 1628.
46. Waterman AD, Schenk EA, Barrett AC, et al. Incompatible kidney donor candidates' willingness to participate in donor-exchange and nondirected donation. Am J Transplant 2006; 6: 1631.
47. Woodle ES, Daller JA, Aeder M, et al. Ethical considerations for participation of nondirected living donors in kidney exchange programs. Am J Transplant 2010; 10: 1460.
48. Gentry SE, Segev DL, Simmerling M, et al. Expanding kidney paired donation through participation by compatible pairs. Am J Transplant 2007; 7: 2361.
49. Bellomo R, Warrillow SJ, Reade MC. Why we should be wary of singlecenter trials. Crit Care Med 2009; 37: 3114.
50. Matas AJ, Sutherland DE, Najarian JS. Evolution of immunosuppression at the University of Minnesota. Transplant Proc 2004; 36(2 suppl): 64S.
51. Matas AJ, Ramcharan T, Paraskevas S, et al. Rapid discontinuation of steroids in living donor kidney transplantation: A pilot study. Am J Transplant 2001; 1: 278.